Newsletter | May 3, 2021

05.03.21 -- Gene Therapy Viral Vectors: An Analysis

 
Sponsor
Featured Editorial
Industry Insights
The Pharma Trends You Need To Know: A CDMO's Perspective

Companies must understand how today’s new pharmaceutical landscape is causing a dramatic shift in how we plan for and execute drug development and manufacturing.

Can Your Lab Meet The Demands Of Today’s Bioprocessing Landscape?

By adapting to today’s demands using smart bioprocessing, you can help drive efficiency in your laboratory and contribute to the economical and reliable production of next-generation molecules.

What Are Exosomes?

Gain an understanding of exosomes, which are recently attracting the attention of researchers as new mediators of cell-cell communication transporting biomolecules such as lipids, proteins, and RNAs in vivo.

Immuno-Oncology In Vitro Assays

In this application note, we discuss our recently developed assay format to characterize checkpoint inhibitor monoclonal antibodies (mAbs), specifically discussing those that target the PD-1 PD-L1 pathway.

FDA Submission Strategies For Cell And Gene Therapies

Industry experts share their cell therapy adoption experiences and discuss emerging trends to accelerate life-saving therapies from the bench to the bedside.

Comparing Different Methods Of Clarification Of Chinese Hamster Ovary (CHO) Cells

In this study, alluvial filtration, depth filtration, and flocculant filtration are evaluated, and the data generated with these three methods at laboratory scale are discussed.

Meet The Scientist: Sundeep Sethia, Ph.D.

Many drug development candidates never advance to the clinic because of bioavailability and solubility challenges, which Dr. Sundeep Sethia has dedicated his life to overcoming.

5,000 L Single-Use Bioreactors: Next-Generation Biologics Manufacturing

Biologics revenues are expected to be worth $450 billion by 2030, from $285 billion in 2020. This growth creates demand for therapeutics, expanding indications and the growing portfolios of biosimilars.

Selecting The Optimal Resins For Monoclonal Antibody (mAb) Process Purification

The development of monoclonal antibody (mAb) technology has led to many innovative discoveries, significantly influencing the direction and progress of research and therapeutics.

Lipid Nanoparticles Are Having A Breakout Moment

Lipid Nanoparticles (NPs) are a proven drug delivery technology to penetrate target cells and ensure release for systematic or local delivery. Their gene and cell therapy potential has become clearer since COVID-19.

Strategies For Optimizing Upstream Processes Cell Culture

The cell culture process is crucial for maximizing the production of biologics and vaccines, optimizing product quality attributes, minimizing impurities, and simplifying operations.

The Biopharmaceutical Factory Of The Future

This infographic identifies market trends challenging biopharma companies, business drivers to meet market needs, as well as requirements and aspirations for the factory of the future.

Lung Cancer Treatment: Dry Powder Inhaler Manufacturing Formulations

Explore case studies where lung cancer therapies were delivered by dry powder inhaler in a rat model and evaluated for efficacy, demonstrating a promising route to treat lung cancer.

Flexible Isolator Technology: Containment That Works

This webinar focuses on applications where flexible isolators have been used, including containment assessments to confirm performance and ergonomic benefits.

21 CFR Part 11 Compliance And Osmolality As A Process Parameter

FDA warning letters due to incomplete data in the pharma and biotech industries can be prevented by ensuring the reliability of electronic records, a process known as compliance with data integrity.

Sponsor
Solutions
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.